{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:29:32Z","timestamp":1785871772905,"version":"3.56.0"},"reference-count":50,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["20 0175 F"],"award-info":[{"award-number":["20 0175 F"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["20 1076PjF"],"award-info":[{"award-number":["20 1076PjF"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["CAN2018\/602"],"award-info":[{"award-number":["CAN2018\/602"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018\u201003301"],"award-info":[{"award-number":["2018\u201003301"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020\u201002367"],"award-info":[{"award-number":["2020\u201002367"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021\u201001628"],"award-info":[{"award-number":["2021\u201001628"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","award":["S17\u20100092"],"award-info":[{"award-number":["S17\u20100092"]}],"id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Basic Clin Pharma Tox"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chemotherapy\u2010induced mucositis, characterized by diarrhoea and villous atrophy, is a severe side effect contributing to reduced quality of life and premature death in cancer patients treated with cytostatics. Despite its high incidence, there is no effective supportive therapy available. The main objective of this study was to determine if the anti\u2010inflammatory drugs anakinra and\/or dexamethasone\u2014which have different mechanisms\u2010of\u2010action\u2014might be used to effectively treat idarubicin\u2010induced mucositis in rats. Mucositis was induced through a single injection with 2\u2009mg\/kg idarubicin (with saline as control), followed by daily treatments of anakinra (100\u2009mg\/kg\/day), dexamethasone (10\u2009mg\/kg\/day) or both for 3\u2009days. After 72\u2009h, jejunal tissue was collected for morphological, apoptotic and proliferative analyses, and colonic faecal water content and body weight change were determined. The diarrhoea that was induced by idarubicin (from 63.5% to 78.6% water content in faeces) was completely reversed by anakinra alone, and the jejunal villus height reduction by 36% was prevented by a combination of anakinra and dexamethasone. Dexamethasone reduced apoptosis in the jejunal crypts, both alone and in combination with anakinra. These positive effects encouraged further investigations into the use of anakinra and dexamethasone as supportive therapies for chemotherapy\u2010induced intestinal mucositis and diarrhoea.<\/jats:p>","DOI":"10.1111\/bcpt.13851","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T03:18:34Z","timestamp":1678159114000},"page":"507-516","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Anakinra and dexamethasone treatment of idarubicin\u2010induced mucositis and diarrhoea in rats"],"prefix":"10.1111","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3764-4198","authenticated-orcid":false,"given":"Fredrik","family":"Kullenberg","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Biosciences Uppsala University  Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Peters","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biosciences Uppsala University  Uppsala Sweden"},{"name":"Department of Medical Cell Biology Uppsala University  Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Sj\u00f6blom","sequence":"additional","affiliation":[{"name":"Department of Medical Cell Biology Uppsala University  Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke","family":"Heindryckx","sequence":"additional","affiliation":[{"name":"Department of Medical Cell Biology Uppsala University  Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5586-2906","authenticated-orcid":false,"given":"David","family":"Dahlgren","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biosciences Uppsala University  Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Lennern\u00e4s","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biosciences Uppsala University  Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,3,20]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33587"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00079"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon\u20102017\u20100418"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520\u2010018\u20104362\u20103"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520\u2010014\u20102395\u20109"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy145"},{"issue":"3","key":"e_1_2_9_9_1","first-page":"227","article-title":"Clinical implications of chemotherapy\u2010induced diarrhea in patients with cancer","volume":"3","author":"Arnold R","year":"2005","journal-title":"J Support Oncol"},{"key":"e_1_2_9_10_1","first-page":"809","volume-title":"Is idarubicin the future of TACE?","author":"Padia SA","year":"2019"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.6374"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0006\u20102952(98)00307\u20104"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113480"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071717"},{"issue":"2","key":"e_1_2_9_15_1","first-page":"152","article-title":"Idarubicin: an anthracycline antineoplastic agent","volume":"11","author":"Cersosimo R","year":"1992","journal-title":"Clin Pharm"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078\u20100432.CCR\u201020\u20104592"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.681417"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105296"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520\u2010019\u201004893\u2010z"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2009.08.006"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/1748\u2010717X\u20105\u201022"},{"key":"e_1_2_9_22_1","volume-title":"Corticosteroid adverse effects","author":"Yasir M","year":"2018"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.2.940"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186511"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1538\/expanim.19\u20100057"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2011.04.013"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010022\u201010700\u20103"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.4103\/0976\u20100105.177703"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.39.9.1255"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102010\u201003\u2010273243"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510470040032"},{"key":"e_1_2_9_32_1","article-title":"Evaluation and validation of chemotherapy\u2010specific diarrhoea and histopathology in rats","author":"Dahlgren D","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476\u20105381.2010.00872.x"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13492"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031021"},{"key":"e_1_2_9_36_1","first-page":"1","article-title":"The progression of doxorubicin\u2010induced intestinal mucositis in rats","author":"Kullenberg F","year":"2022","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"e_1_2_9_37_1","first-page":"760","volume-title":"Neutropenic colitis after treatment of acute myelogenous leukemia with idarubicin and cytosine arabinoside","author":"Hogan WJ","year":"2002"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23080"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.3009"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280\u2010020\u201004186\u2010x"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2014.03.007"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020433"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201900788RR"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.9b00012"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01157"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000000335"},{"issue":"3","key":"e_1_2_9_47_1","article-title":"Dexamethasone co\u2010medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo\u2010immunotherapy strategies","volume":"5","author":"Cook AM","year":"2016","journal-title":"Onco Targets Ther"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/jop.12473"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/NOR.0000000000000595"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600\u20100676.1988.tb00992.x"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039\u2010128X(03)00084\u20109"}],"container-title":["Basic &amp; Clinical Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcpt.13851","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bcpt.13851","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcpt.13851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T05:53:17Z","timestamp":1694411597000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bcpt.13851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,20]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1111\/bcpt.13851"],"URL":"https:\/\/doi.org\/10.1111\/bcpt.13851","archive":["Portico"],"relation":{},"ISSN":["1742-7835","1742-7843"],"issn-type":[{"value":"1742-7835","type":"print"},{"value":"1742-7843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,20]]},"assertion":[{"value":"2022-10-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}